Page last updated: 2024-11-05

cerous chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

cerous chloride: RN given refers to cpd with MF CeCl3 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161282
CHEBI ID35458
MeSH IDM0087407

Synonyms (33)

Synonym
cerium(iii) chloride, anhydrous
[cecl3]
cecl3
cerium(3+) chloride
trichloridocerium
cerous(iii) chloride
CHEBI:35458
nsc 84267
einecs 232-227-8
ai3-51764
ccris 6888
wln: ce g3
cerium trichloride
cerium chloride, cecl3
cerium chloride (cecl3)
7790-86-5
cerous chloride
nsc84267
cerium(iii) chloride, anhydrous, beads, -10 mesh, >=99.99% trace metals basis
cerium(iii) chloride, anhydrous, beads, -10 mesh, 99.9%
trichlorocerium
ec 232-227-8
unii-th8e3ie00v
cerium chloride;cerium trichloride;cerium(iii) chloride;cerous chloride;cerium(iii) chloride, anhydrous,??cecl3
SC10975
cerium(iii) chloride, anhydrous,cecl3
cerium(iii) chloride, ultra dry
cerium(iii) chloride beads
cerium(iii) chloride powder
cerium(iii) chloride, anhydrous (h2o < 0.5%)
mfcd00010929
cerium (iii) chloride, ultra dry, powder, ampoule, 99.9% trace metals basis
Q419806

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"232Th and Ce (III) toxic effects and its modifications with caffeine and D,L-buthionine-(S,R)-sulphoximine on Chlorella vulgaris Beijer were studied using an optical density measure after 24 hours growth."( [The mechanisms of 232Th and of Ce (III) toxic action on Chlorella vulgaris Beijer. Estimation of 232Th radiation impact contribution into toxic effect induced].
Belykh, ES; Evseeva, TI; Geras'kin, SA; Maĭstrenko, TA,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cerium coordination entity
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (68)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (10.29)18.7374
1990's9 (13.24)18.2507
2000's16 (23.53)29.6817
2010's34 (50.00)24.3611
2020's2 (2.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other69 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]